Delivering a landmark address at the recent BAJCAN Cannabis Expo held at Bridgetown’s Hilton Hotel last Friday, Barbados’ Minister of Agriculture, Food and Nutritional Security Dr Shantal Munro-Knight laid out a bold national roadmap to position the eastern Caribbean island as a leading regional epicenter for cannabis-focused biotechnology and cutting-edge research. The centerpiece of the government’s strategy is the development of one of the Caribbean’s most advanced tissue culture laboratories, scheduled to launch in the St Philip parish before the end of the current calendar year, purpose-built to meet strict international quality and safety benchmarks. A dedicated national cannabis seed bank will follow shortly after the lab’s launch, designed to safeguard the archipelago’s unique indigenous cannabis genetic strains from unauthorised external appropriation, a measure the minister framed as a critical investment in long-term local intellectual property sovereignty.
Citing explosive growth in the global medicinal cannabis sector, which hit a valuation of $19.7 billion in 2025 and is on track to surge to $26.9 billion in 2026, Dr Munro-Knight emphasized that Caribbean nations collectively hold unprecedented untapped potential to carve out competitive advantages across high-value segments including specialized biotech research, standardized third-party product testing, and evidence-based therapeutic innovation. A former inaugural chief executive officer of the Barbados Medicinal Cannabis Licensing Authority (BMCLA), the minister drew on her first-hand experience building the local industry from scratch to outline the layered, systemic hurdles that small island developing states (SIDS) face in scaling the sector.
The most pervasive unaddressed barrier, she noted, is the long-documented “elephant in the room” of global banking restrictions, which she described as a systemic, cross-border challenge rather than a flaw in domestic regulatory frameworks. Risk-averse global financial institutions continue to carry deep historical bias against communities with longstanding cultural ties to cannabis, creating de facto exclusion from standard financial services for legitimate licensed cannabis operators across the region. Even with recent shifts in global policy including the United States’ formal rescheduling of cannabis under federal drug laws, SIDS remain locked out of equitable access to global capital flows by a global financial system structured around Anglo-Saxon liberal capital capture, she explained.
Additional persistent challenges include deep-seated public stigma rooted in decades of cultural and legal prohibition, widespread public confusion between evidence-based medicinal cannabis applications and unregulated recreational use, and lingering public anxiety about unforeseen societal harms that require sustained, targeted public education campaigns to counter. To illustrate the plant’s tangible therapeutic value, Dr Munro-Knight shared a personal anecdote about her own father, who lives with debilitating chronic muscle spasms and relies on regulated medicinal cannabis oil to manage his symptoms and maintain quality of life, reinforcing the urgent need to center patient outcomes in all industry regulatory design.
Rejecting fragmented, nation-by-nation approaches to industry development, the minister issued a rousing call to action for all Caribbean industry stakeholders, regulators, and policymakers to align on shared regional standards for testing, intellectual property protection, and cross-border advocacy to push back against discriminatory global financial barriers. “The systemic headwinds stacked against small island states in this space cannot be overcome by any single nation acting alone,” she told expo attendees. “Our path to long-term, sustainable success lies in coordinated regional collaboration, rather than isolated national strategies.”